Cargando…
Systemically Administered, Target Organ-Specific Therapies for Regenerative Medicine
Growth factors and other agents that could potentially enhance tissue regeneration have been identified, but their therapeutic value in clinical medicine has been limited for reasons such as difficulty to maintain bioactivity of locally applied therapeutics in the protease-rich environment of regene...
Autores principales: | Järvinen, Tero A. H., May, Ulrike, Prince, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632713/ https://www.ncbi.nlm.nih.gov/pubmed/26437400 http://dx.doi.org/10.3390/ijms161023556 |
Ejemplares similares
-
Systemically Administered, Target-Specific, Multi-Functional Therapeutic Recombinant Proteins in Regenerative Medicine
por: Järvinen, Tero A.H., et al.
Publicado: (2020) -
Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology
por: Iqbal, Aqsa, et al.
Publicado: (2021) -
Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)
por: Vähätupa, Maria, et al.
Publicado: (2021) -
Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition
por: Järvinen, Tero A. H., et al.
Publicado: (2015) -
Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic Therapies
por: Coentro, João Q., et al.
Publicado: (2021)